WO2012103398A9 - Methods for treating obstructive sleep apnea - Google Patents

Methods for treating obstructive sleep apnea Download PDF

Info

Publication number
WO2012103398A9
WO2012103398A9 PCT/US2012/022825 US2012022825W WO2012103398A9 WO 2012103398 A9 WO2012103398 A9 WO 2012103398A9 US 2012022825 W US2012022825 W US 2012022825W WO 2012103398 A9 WO2012103398 A9 WO 2012103398A9
Authority
WO
WIPO (PCT)
Prior art keywords
methods
sleep apnea
obstructive sleep
treating obstructive
treating
Prior art date
Application number
PCT/US2012/022825
Other languages
French (fr)
Other versions
WO2012103398A2 (en
Inventor
Jian-Qiang Fan
Original Assignee
Jian-Qiang Fan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jian-Qiang Fan filed Critical Jian-Qiang Fan
Priority to CN2012800065522A priority Critical patent/CN103458899A/en
Priority to EP12739245.4A priority patent/EP2672972B1/en
Priority to JP2013551354A priority patent/JP2014503593A/en
Priority to CA2825309A priority patent/CA2825309C/en
Publication of WO2012103398A2 publication Critical patent/WO2012103398A2/en
Publication of WO2012103398A9 publication Critical patent/WO2012103398A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/56—Devices for preventing snoring
    • A61F5/566—Intra-oral devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057—Pumps therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
PCT/US2012/022825 2011-01-28 2012-01-27 Methods for treating obstructive sleep apnea WO2012103398A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN2012800065522A CN103458899A (en) 2011-01-28 2012-01-27 Methods for treating obstructive sleep apnea
EP12739245.4A EP2672972B1 (en) 2011-01-28 2012-01-27 Methods for treating obstructive sleep apnea
JP2013551354A JP2014503593A (en) 2011-01-28 2012-01-27 Method for treating obstructive sleep apnea
CA2825309A CA2825309C (en) 2011-01-28 2012-01-27 Pyridostigmine for the treatment of obstructive sleep apnea

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161437272P 2011-01-28 2011-01-28
US61/437,272 2011-01-28

Publications (2)

Publication Number Publication Date
WO2012103398A2 WO2012103398A2 (en) 2012-08-02
WO2012103398A9 true WO2012103398A9 (en) 2012-09-27

Family

ID=46577943

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/022825 WO2012103398A2 (en) 2011-01-28 2012-01-27 Methods for treating obstructive sleep apnea

Country Status (6)

Country Link
US (2) US8753327B2 (en)
EP (1) EP2672972B1 (en)
JP (2) JP2014503593A (en)
CN (2) CN107007602A (en)
CA (1) CA2825309C (en)
WO (1) WO2012103398A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012103398A2 (en) * 2011-01-28 2012-08-02 Jian-Qiang Fan Methods for treating obstructive sleep apnea
AU2014385794B2 (en) * 2014-03-03 2020-05-07 Sleep Innovations Pty Ltd Device and method for sleep apnoea treatment
WO2016014229A1 (en) * 2014-07-25 2016-01-28 Mendelowitz David Oxytocin improves treatment of obstructive sleep apnea
JP6480598B2 (en) 2015-04-02 2019-03-13 ヒル−ロム サービシーズ プライヴェート リミテッド Respirator manifold
WO2018115351A1 (en) * 2016-12-23 2018-06-28 Koninklijke Philips N.V. System for treating snoring among at least two users
SG11201909973UA (en) * 2017-04-28 2019-11-28 Brigham & Womens Hospital Inc Methods and compositions for treating sleep apnea
KR20200115598A (en) 2018-01-30 2020-10-07 애프니메드, 인코포레이티드 (델라웨어) Methods and compositions for treating sleep apnea
WO2019246145A1 (en) * 2018-06-18 2019-12-26 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
CN112601568A (en) * 2018-08-24 2021-04-02 皇家飞利浦有限公司 Providing sleep therapy with a pressure therapy system
US11654283B2 (en) 2019-03-06 2023-05-23 Medtronic Xomed, Inc. Obstructive sleep apnea patient programmer for implantable devices
CN114504643B (en) * 2021-12-24 2024-03-26 北京大学第一医院 Use of anti-IgE antibodies for the treatment of OSAS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2247662B (en) 1990-08-31 1994-11-02 Instance Ltd David J Labels and manufacture thereof
SE9504537D0 (en) 1995-12-19 1995-12-19 Jan Hedner Ways of treating and diagnosing respiratory disorders during sleep and means of performing the method
JP2007502297A (en) * 2003-08-13 2007-02-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Treatment of sleep disorders with cholinesterase inhibitors
CA2622721A1 (en) * 2005-09-16 2007-03-22 Cereuscience Ab Method and means of preventing and treating sleep disordered breathing
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US7984714B2 (en) * 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
WO2012103398A2 (en) * 2011-01-28 2012-08-02 Jian-Qiang Fan Methods for treating obstructive sleep apnea

Also Published As

Publication number Publication date
CA2825309A1 (en) 2012-08-02
US20120197235A1 (en) 2012-08-02
EP2672972B1 (en) 2020-11-04
CN107007602A (en) 2017-08-04
JP2017095485A (en) 2017-06-01
EP2672972A2 (en) 2013-12-18
WO2012103398A2 (en) 2012-08-02
US20140238412A1 (en) 2014-08-28
US9295670B2 (en) 2016-03-29
US8753327B2 (en) 2014-06-17
JP2014503593A (en) 2014-02-13
CA2825309C (en) 2019-10-01
EP2672972A4 (en) 2014-09-10
JP6342525B2 (en) 2018-06-13
CN103458899A (en) 2013-12-18

Similar Documents

Publication Publication Date Title
EP2720632B8 (en) Devices for treating nasal airways
WO2012103398A9 (en) Methods for treating obstructive sleep apnea
EP2755720A4 (en) Systems and methods for apnea therapy
EP2788081A4 (en) Sleep apnea control device
IL224852A (en) Apparatus and method for dignosing obstructive sleep apnea
EP2557921A4 (en) Methods for treatment of sleep-related breathing disorders
EP2691149A4 (en) System and method for treating apnea using evoked swallow
EP2674396A4 (en) Method for producing graphene and graphene
LT2489670T (en) Method for producing amino acid-chelate compounds, amino acid-chelate compounds and use of amino acid-chelate compounds
PL2678035T3 (en) Phenalene-1-one derivatives, method for producing same and use thereof
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
EP2670465A4 (en) Improved artificial airway
EP2699233A4 (en) A method for the treatment of a solid tumour
SG10201604976RA (en) Hydroxy-aminopolymers and method for producing same
EP2861244A4 (en) Sleep apnea treatment
EP2765190A4 (en) Mutant y-glutamyltransferase, and method for producing y-glutamylvalylglycine or salt thereof
HK1197406A1 (en) Crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate, crystal of 5- hydroxy-1h-imidazole-4-carboxamide 3/4 hydrate, and method for producing same 5--1h--4- 5--1h--4-3/4
SG11201400287XA (en) Methods for producing biocompatible materials
EP2583971A4 (en) Method for producing carbodiimide
EP2719283A4 (en) Breads having novel physical properties and method for producing same
AU2011904373A0 (en) Method and formulaiton for inhalation II
AU2011904469A0 (en) Method and Apparatus for the Treatment of Snoring and Sleep Apnoea
AU2011900332A0 (en) Improved Artificial Airway
IL219621A (en) Diaper and method for production thereof
AU2010903945A0 (en) Intra-Hemispheric Asynchrony Time Series for Representation of Sleep Apnea

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12739245

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2825309

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2013551354

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012739245

Country of ref document: EP